← Eichor
Study identifier: NCT07019857 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Thymectomy on Immunity in Infants After Cardiac Surgery

Condition: Congenital Heart Defects · Thymectomy · Immunological Deficiency Syndrome  ·  Sponsor: Nantes University Hospital

PhaseNA
Planned participants70
Who can joinAll sexes, N/A to 6 Months
Healthy volunteersNo

About this study

Heart surgery in infants typically involves complete removal of the thymus gland to improve access to the heart. However, the thymus plays a key role in developing the immune system in early childhood, especially in the production and maturation of T lymphocytes, which help the body defend itself against infections. The THYMIC study tests the hypothesis that partial removal of the thymus (partial thymectomy) during heart surgery may better preserve the child's immune function compared to total removal (complete thymectomy). The goal is to determine whether this conservative surgical approach could reduce the risk of immune system impairment and infections in the months following surgery. This is a prospective, interventional, single-center study conducted at CHU de Nantes, involving 3 groups of infants: * One group undergoing heart surgery with complete thymectomy; * One group undergoing heart surgery with partial thymectomy; * One control group undergoing heart or non-heart surgery without thymus removal. All infants enrolled will have two blood tests: one taken during their surgery and one taken one year later. These blood tests will quantify immune cells (T, B, NK cells), levels of antibodies, and vaccine responses. Parents will also be asked to fill out a questionnaire to record any infections their child experiences during the year after surgery. By comparing the immune responses and infection rates among the groups, the researchers hope to better understand the long…

This description comes directly from the study's public registry record.

Talk to the study team

Alexis Chenouard, PH  ·  02 44 76 82 21  ·  alexis.chenouard@chu-nantes.fr

Evelyne Gauvard  ·  Evelyne.GAUVARD@chu-nantes.fr

Always discuss trial participation with your own doctor first.

Locations (2)

CHU de NantesNantes, FranceNot Yet Recruiting
Chu de NantesNantes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07019857